EBITDA Summary of PhytoHealth Corporation

PhytoHealth Corporation's latest annual EBITDA in 2023 was -20.69 Million TWD , up 66.63% from previous year.
PhytoHealth Corporation's latest quarterly EBITDA in 2024 Q2 was -16.91 Million TWD , up 63.85% from previous quarter.
PhytoHealth Corporation reported an annual EBITDA of -61.97 Million TWD in 2022, down -46.29% from previous year.
PhytoHealth Corporation reported an annual EBITDA of -42.29 Million TWD in 2021, up 30.53% from previous year.
PhytoHealth Corporation reported a quarterly EBITDA of -16.91 Million TWD for 2024 Q2, up 63.85% from previous quarter.
PhytoHealth Corporation reported a quarterly EBITDA of -54.31 Million TWD for 2024 Q3, down -9.32% from previous quarter.

Annual EBITDA Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual EBITDA of PhytoHealth Corporation (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	-20.69 Million TWD	66.63%
2022	-61.97 Million TWD	-46.29%
2021	-42.29 Million TWD	30.53%
2020	-61.12 Million TWD	56.25%
2019	-139.41 Million TWD	9.34%
2018	-153.87 Million TWD	29.49%
2017	-193.72 Million TWD	-14.63%
2016	-190.58 Million TWD	-0.91%
2015	-218.5 Million TWD	35.81%
2014	-293.91 Million TWD	-104.15%
2013	-143.97 Million TWD	-39.53%
2012	-90.92 Million TWD	36.26%
2011	-172.33 Million TWD	8.04%
2010	-197.31 Million TWD	13.2%
2009	-245.6 Million TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-32.25 Million TWD	-24.35%
2024 Q2	-16.91 Million TWD	63.85%
2024 Q3	-54.31 Million TWD	-9.32%
2023 Q3	12.85 Million TWD	240.59%
2023 Q4	-21.78 Million TWD	-269.54%
2023 FY	- TWD	66.63%
2023 Q1	-2.62 Million TWD	92.82%
2023 Q2	-9.14 Million TWD	-248.59%
2022 Q2	-12.66 Million TWD	39.55%
2022 Q3	8.09 Million TWD	163.89%
2022 Q4	-36.5 Million TWD	-551.22%
2022 Q1	-20.94 Million TWD	10.6%
2022 FY	- TWD	-46.29%
2021 Q2	-18.95 Million TWD	12.28%
2021 Q4	-23.43 Million TWD	-208.48%
2021 FY	- TWD	30.53%
2021 Q1	-21.6 Million TWD	-22.28%
2021 Q3	21.59 Million TWD	213.94%
2020 Q3	-22.31 Million TWD	-266.07%
2020 Q2	13.43 Million TWD	138.96%
2020 Q1	-34.49 Million TWD	52.44%
2020 Q4	-17.67 Million TWD	20.81%
2020 FY	- TWD	56.25%
2019 Q3	-31.36 Million TWD	-193.28%
2019 FY	- TWD	9.34%
2019 Q1	-24.93 Million TWD	70.41%
2019 Q2	-10.69 Million TWD	57.11%
2019 Q4	-72.52 Million TWD	-131.28%
2018 Q2	-23.01 Million TWD	-233.86%
2018 FY	- TWD	29.49%
2018 Q4	-84.25 Million TWD	-112.19%
2018 Q3	-39.7 Million TWD	-72.53%
2018 Q1	-6.89 Million TWD	92.7%
2017 Q3	-46.79 Million TWD	-29.92%
2017 FY	- TWD	-14.63%
2017 Q2	-36.01 Million TWD	12.21%
2017 Q4	-94.38 Million TWD	-101.7%
2017 Q1	-41.02 Million TWD	8.43%
2016 Q1	-54.81 Million TWD	-63.58%
2016 FY	- TWD	-0.91%
2016 Q3	-38.97 Million TWD	24.64%
2016 Q4	-44.8 Million TWD	-14.94%
2016 Q2	-51.72 Million TWD	5.64%
2015 Q1	-72.98 Million TWD	19.45%
2015 Q2	-60.18 Million TWD	17.53%
2015 Q3	-30.37 Million TWD	49.52%
2015 Q4	-33.5 Million TWD	-10.3%
2015 FY	- TWD	35.81%
2014 Q4	-90.6 Million TWD	-25.29%
2014 Q2	-104.95 Million TWD	-302.95%
2014 FY	- TWD	-104.15%
2014 Q1	-26.04 Million TWD	76.85%
2014 Q3	-72.31 Million TWD	31.1%
2013 Q3	-33.44 Million TWD	-89.44%
2013 Q1	19.65 Million TWD	167.1%
2013 FY	- TWD	-39.53%
2013 Q4	-112.51 Million TWD	-236.39%
2013 Q2	-17.65 Million TWD	-189.85%
2012 Q3	-13.01 Million TWD	45.92%
2012 Q2	-24.06 Million TWD	3.07%
2012 Q1	-24.82 Million TWD	23.06%
2012 Q4	-29.28 Million TWD	-125.04%
2012 FY	- TWD	36.26%
2011 Q1	-51.81 Million TWD	17.92%
2011 FY	- TWD	8.04%
2011 Q4	-32.26 Million TWD	27.89%
2011 Q3	-44.74 Million TWD	-35.31%
2011 Q2	-33.06 Million TWD	36.18%
2010 FY	- TWD	13.2%
2010 Q4	-63.13 Million TWD	-77.72%
2010 Q1	-32.75 Million TWD	0.0%
2010 Q2	-44.64 Million TWD	-36.3%
2010 Q3	-35.52 Million TWD	20.43%
2009 FY	- TWD	0.0%

Peer EBITDA Comparison of PhytoHealth Corporation

Name	EBITDA	EBITDA Difference
Grape King Bio Ltd	2.88 Billion TWD	100.717%
Standard Chem & Pharm CO., LTD.	1.57 Billion TWD	101.311%
Maywufa Company Ltd.	239.81 Million TWD	108.631%
ScinoPharm Taiwan, Ltd.	819.15 Million TWD	102.527%
Lotus Pharmaceutical Co., Ltd.	6.87 Billion TWD	100.301%
LIWANLI Innovation Co., Ltd.	6.81 Million TWD	403.935%
YungShin Global Holding Corporation	1.35 Billion TWD	101.525%
SCI Pharmtech, Inc.	529.61 Million TWD	103.908%
Formosa Laboratories, Inc.	1.16 Billion TWD	101.779%
PharmaEssentia Corporation	-671.48 Million TWD	96.918%
Bora Pharmaceuticals Co., LTD.	5.73 Billion TWD	100.361%

Global Stocks Search

PhytoHealth Corporation (4108.TW)

EBITDA Summary of PhytoHealth Corporation

Annual EBITDA Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual EBITDA of PhytoHealth Corporation (2023 - 2009)

Peer EBITDA Comparison of PhytoHealth Corporation